Strategic partnerships Texas Biomed actively pursues collaborations with industry and government partners (Island Pharmaceuticals, U.S. Department of War, Flyttr) to advance drug development, countermeasures, and pest management. This indicates receptiveness to co-development, CRADA-like arrangements, and milestone-driven engagements.

Countermeasure capabilities The institution develops medical countermeasures against emerging and high-consequence pathogens, including Ebola and other viruses, suggesting opportunities to offer specialized contract research, antiviral screening, and translational support services aligned with national security and public health contracts.

High containment expertise Home to the nation’s only privately owned BSL-4 lab, Texas Biomed has unique facilities for lethal pathogen research, creating potential for high-value collaborations in regulated testing, vaccine/therapeutic evaluation, and safety-compliant computational modeling partnerships.

Genomics computing edge With the AT&T Genomics Computing Center housing a world-class high-performance cluster, there is a compelling case to offer cloud-ready data analytics, large-scale genomics pipelines, and HPC-enabled consultancy to accelerate genetic discovery and drug target identification.

Education and outreach momentum Recent partnerships with Valero Energy for science education programs indicate a channel for corporate sponsorships, workforce development collaborations, and potential training or internship programs that could open pathways to sponsor-funded research initiatives or talent pipelines.